Classification of patients according to eGFR and proteinuria categories at 3 and 12 months
| . | 12-month eGFR . | . | |||
|---|---|---|---|---|---|
| 3-month eGFR . | <30 (%) . | 30–45 (%) . | 45–60 (%) . | >60 (%) . | Total (%) . |
| <30 | 30 (56.7) | 22 (41.5) | 1 (1.8) | 0 (0.0) | 53 (7.3) |
| 30–45 | 19 (7.9) | 150 (62.8) | 65 (27.2) | 5 (2.1) | 239 (32.7) |
| 45–60 | 3 (1.2) | 63 (24.6) | 142 (55.5) | 48 (18.7) | 256 (35.0) |
| >60 | 4 (2.2) | 2 (1.1) | 56 (30.6) | 121 (66.1) | 183 (25.0) |
| 12-month proteinuria | |||||
| 3-month proteinuria | <0.5 (%) | 0.5–1.0 (%) | 1.0–2.0 (%) | >2 (%) | Total (%) |
| <0.5 | 365 (69.5) | 40 (7.6) | 15 (2.9) | 4 (0.8) | 424 (80.8) |
| 0.5–1.0 | 41 (7.8) | 15 (2.9) | 6 (1.1) | 2 (0.4) | 64 (12.2) |
| 1.0–2.0 | 4 (0.8) | 5 (1.0) | 10 (1.9) | 4 (0.8) | 23 (4.4) |
| >2.0 | 2 (0.4) | 2 (0.4) | 3 (0.6) | 7 (1.3) | 14 (2.7) |
| . | 12-month eGFR . | . | |||
|---|---|---|---|---|---|
| 3-month eGFR . | <30 (%) . | 30–45 (%) . | 45–60 (%) . | >60 (%) . | Total (%) . |
| <30 | 30 (56.7) | 22 (41.5) | 1 (1.8) | 0 (0.0) | 53 (7.3) |
| 30–45 | 19 (7.9) | 150 (62.8) | 65 (27.2) | 5 (2.1) | 239 (32.7) |
| 45–60 | 3 (1.2) | 63 (24.6) | 142 (55.5) | 48 (18.7) | 256 (35.0) |
| >60 | 4 (2.2) | 2 (1.1) | 56 (30.6) | 121 (66.1) | 183 (25.0) |
| 12-month proteinuria | |||||
| 3-month proteinuria | <0.5 (%) | 0.5–1.0 (%) | 1.0–2.0 (%) | >2 (%) | Total (%) |
| <0.5 | 365 (69.5) | 40 (7.6) | 15 (2.9) | 4 (0.8) | 424 (80.8) |
| 0.5–1.0 | 41 (7.8) | 15 (2.9) | 6 (1.1) | 2 (0.4) | 64 (12.2) |
| 1.0–2.0 | 4 (0.8) | 5 (1.0) | 10 (1.9) | 4 (0.8) | 23 (4.4) |
| >2.0 | 2 (0.4) | 2 (0.4) | 3 (0.6) | 7 (1.3) | 14 (2.7) |
Classification of patients according to eGFR and proteinuria categories at 3 and 12 months
| . | 12-month eGFR . | . | |||
|---|---|---|---|---|---|
| 3-month eGFR . | <30 (%) . | 30–45 (%) . | 45–60 (%) . | >60 (%) . | Total (%) . |
| <30 | 30 (56.7) | 22 (41.5) | 1 (1.8) | 0 (0.0) | 53 (7.3) |
| 30–45 | 19 (7.9) | 150 (62.8) | 65 (27.2) | 5 (2.1) | 239 (32.7) |
| 45–60 | 3 (1.2) | 63 (24.6) | 142 (55.5) | 48 (18.7) | 256 (35.0) |
| >60 | 4 (2.2) | 2 (1.1) | 56 (30.6) | 121 (66.1) | 183 (25.0) |
| 12-month proteinuria | |||||
| 3-month proteinuria | <0.5 (%) | 0.5–1.0 (%) | 1.0–2.0 (%) | >2 (%) | Total (%) |
| <0.5 | 365 (69.5) | 40 (7.6) | 15 (2.9) | 4 (0.8) | 424 (80.8) |
| 0.5–1.0 | 41 (7.8) | 15 (2.9) | 6 (1.1) | 2 (0.4) | 64 (12.2) |
| 1.0–2.0 | 4 (0.8) | 5 (1.0) | 10 (1.9) | 4 (0.8) | 23 (4.4) |
| >2.0 | 2 (0.4) | 2 (0.4) | 3 (0.6) | 7 (1.3) | 14 (2.7) |
| . | 12-month eGFR . | . | |||
|---|---|---|---|---|---|
| 3-month eGFR . | <30 (%) . | 30–45 (%) . | 45–60 (%) . | >60 (%) . | Total (%) . |
| <30 | 30 (56.7) | 22 (41.5) | 1 (1.8) | 0 (0.0) | 53 (7.3) |
| 30–45 | 19 (7.9) | 150 (62.8) | 65 (27.2) | 5 (2.1) | 239 (32.7) |
| 45–60 | 3 (1.2) | 63 (24.6) | 142 (55.5) | 48 (18.7) | 256 (35.0) |
| >60 | 4 (2.2) | 2 (1.1) | 56 (30.6) | 121 (66.1) | 183 (25.0) |
| 12-month proteinuria | |||||
| 3-month proteinuria | <0.5 (%) | 0.5–1.0 (%) | 1.0–2.0 (%) | >2 (%) | Total (%) |
| <0.5 | 365 (69.5) | 40 (7.6) | 15 (2.9) | 4 (0.8) | 424 (80.8) |
| 0.5–1.0 | 41 (7.8) | 15 (2.9) | 6 (1.1) | 2 (0.4) | 64 (12.2) |
| 1.0–2.0 | 4 (0.8) | 5 (1.0) | 10 (1.9) | 4 (0.8) | 23 (4.4) |
| >2.0 | 2 (0.4) | 2 (0.4) | 3 (0.6) | 7 (1.3) | 14 (2.7) |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
